- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Breast cancer (BRCA) 2
Total 126536 results
-
Dana-Farber Cancer InstitutePuma Biotechnology, Inc.; Translational Breast Cancer Research ConsortiumActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; University of California, Los Angeles; Dana-Farber... and other collaboratorsActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingScreening Breast MRI in Patients Who Are BRCA Mutation CarriersUnited States
-
AstraZenecaTerminated
-
Assiut UniversityNot yet recruiting
-
Fundación Pública Andaluza para la gestión de la...Completed
-
Atossa Therapeutics, Inc.WithdrawnBreast Cancer, Preneoplastic Conditions, BRCAIsrael
-
Yonsei UniversityNot yet recruitingTNBC - Triple-Negative Breast CancerKorea, Republic of
-
Institut Paoli-CalmettesUNICANCER - Le Groupe génétique et cancer (GGC)RecruitingBreast Cancers | Ovarian CancersFrance
-
Jules Bordet InstituteActive, not recruitingBreast CancerUnited States, Belgium, Israel, France, Italy, Spain, Brazil, Mexico, Poland, Portugal, Switzerland
-
Georgetown UniversityGeorge Washington UniversityEnrolling by invitation
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Istituto Oncologico di BariCompletedBreast Cancer | BRCA1 Mutation | BRCA2 Mutation | Dietary ModificationItaly
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
Radboud University Medical CenterUnknown
-
Beth Israel Deaconess Medical CenterWashington University School of Medicine; Rush University Medical Center; Wake... and other collaboratorsRecruitingPancreatic Cancer, AdultUnited States
-
Banaras Hindu UniversityRecruiting
-
European Institute of OncologyCompletedBRCA1 Mutation | BRCA2 Mutation | Psychosocial FactorsItaly
-
zr Pharma & GmbHCompletedPancreatic Cancer | Pancreatic Ductal AdenocarcinomaUnited States, Israel
-
University of Alabama at BirminghamTerminatedOvarian Cancer | Resistant BRCA Wild-Type Ovarian CancerUnited States
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
Song HongpingRecruiting
-
European Organisation for Research and Treatment...AstraZenecaWithdrawnBRCA1 Mutation | BRCA2 Mutation | TNBC - Triple-Negative Breast Cancer
-
Dana-Farber Cancer InstituteCompleted
-
AstraZenecaQuintiles; University of Tubingen - GermanyCompletedBreast CancerUnited States, Bulgaria, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Canada, Poland, Australia, Hungary, Taiwan, Japan, Germany, United Kingdom
-
Dana-Farber Cancer InstituteCompleted
-
Memorial Sloan Kettering Cancer CenterCold Spring Harbor LaboratoryActive, not recruiting
-
Beth Israel Deaconess Medical CenterActive, not recruiting
-
PharmaMarCompletedBreast CancerUnited States, Spain
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneWithdrawn
-
AbbVieCompletedOncology | High Grade Serous Ovarian Cancer | BRCA Mutated | BRCA Mutated Breast Cancer
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
Lynkcell EuropeEnrolling by invitationBreast Cancer | Breast Neoplasms | Ovarian Neoplasms | Ovarian Cancer | HER2-positive Breast Cancer | HER2-negative Breast Cancer | HER-2 Protein Overexpression | BRCA MutationUkraine
-
Bakirkoy Dr. Sadi Konuk Research and Training HospitalRecruiting
-
Dana-Farber Cancer InstituteJohns Hopkins University; GlaxoSmithKline; Translational Breast Cancer Research...RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer | Deleterious PALB2 Gene Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene MutationUnited States
-
Dana-Farber Cancer InstituteAstraZeneca; Cyclacel Pharmaceuticals, Inc.Active, not recruiting
-
Columbia UniversityCompleted
-
Mersin UniversityRecruiting
-
National Cancer Institute, NaplesRecruitingBRCA Wild Type Platinum Sensitive Recurrent Ovarian CancerItaly
-
IDEAYA BiosciencesRecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | Advanced or Metastatic Solid TumorsUnited States
-
Zagazig UniversityUnknownSecond Trimester AbortionEgypt
-
Peking University People's HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Enrolling by invitationGermline BRCA-mutated HER2-negative Breast CancerChina
-
AstraZenecaCompleted
-
AstraZenecaActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Germany, Austria, Israel, Australia
-
Akdeniz UniversityRecruiting
-
Pamela MunsterQuantumLeap Healthcare CollaborativeTerminatedTriple Negative Metastatic Breast Cancer | BRCA-mutated Solid TumorUnited States
-
Georgetown UniversityRecruiting
-
Centre Oscar LambretCTD-CNO; Laboratoire PRISMActive, not recruitingBRCA1 Mutation | BRCA2 Mutation | Hereditary Breast and Ovarian CancerFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed